Alarming trends and disparities in high-risk endometrial cancer
- 13 October 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 35 (1) , 15-20
Abstract
Purpose of review: To summarize the most recent publications highlighting the trends and disparities among patients diagnosed with high-risk endometrial cancer. Recent findings: Endometrial cancer mortality continues to rise, driven by the increasing incidence of high-risk histologic subtypes that accounts for a disproportionate number of endometrial cancer deaths. The lack of progress made in endometrial cancer treatment, particularly of high-risk histologic subtypes, disproportionately affects black women who are more likely to be diagnosed with these aggressive tumor types. Even when accounting for high-risk histology, various factors across the spectrum of care may influence the survival disparities between black and white women, including timely access to guideline-concordant care, clinical trial enrollment, and systemic racism that impacts cancer outcomes. Summary: In this review, we highlight the disproportionate impact of worsening endometrial cancer mortality and healthcare inequalities contributing to the endometrial cancer survival disparity between black and white women.Keywords
This publication has 39 references indexed in Scilit:
- Impact of quality of care on racial disparities in survival for endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2020
- Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatmentAmerican Journal of Obstetrics and Gynecology, 2020
- Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid CancersJournal of Clinical Oncology, 2019
- Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neuJournal of Clinical Oncology, 2018
- Endometrial cancer disparities: a race-conscious critique of the literatureAmerican Journal of Obstetrics and Gynecology, 2018
- Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignanciesGynecologic Oncology, 2018
- Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United StatesCA: A Cancer Journal for Clinicians, 2017
- Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysisGynecologic Oncology, 2017
- Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality CareObstetrics & Gynecology, 2013
- Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic StatusJNCI: Journal of the National Cancer Institute, 2013